Skip to main content
Equibles

ALPS ADVISORS INC

Position in TARS — Tarsus Pharmaceuticals, Inc.

CIK 1376113 Denver, CO
Back to TARS Full portfolio

Position in TARS

as of Jun 30, 2026 · filed Jul 29, 2026
Position Value
$2,729,393
+$298,906 QoQ
Shares Held
43,365
+25.2% QoQ
Ownership
0.099%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#87
of 256 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in TARS Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

ALPS ADVISORS INC holds $213,436,831 across 115 Biotechnology names. TARS ranks #24 (1.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 315,335 $17,680,833
2 APGE
Apogee Therapeutics, Inc.
 62,523 $8,298,677
3 CGON
CG Oncology, Inc.
 89,218 $6,338,938
4 XENE
Xenon Pharmaceuticals Inc.
 97,610 $5,891,739
5 ORKA
Oruka Therapeutics, Inc.
 61,014 $5,806,702
6 DNTH
Dianthus Therapeutics, Inc. /DE/
 55,281 $5,388,791
7 TVTX
Travere Therapeutics, Inc.
 93,981 $5,339,060
8 DFTX
Definium Therapeutics, Inc.
 110,388 $5,192,651

All Filings in TARS

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $2,729,393 43,365
2026-03-31 $2,430,487 34,647
2025-12-31 $2,845,739 34,755
2025-09-30 $1,274,892 21,452
2025-06-30 $918,685 22,678
2025-03-31 $1,429,935 27,836
2024-12-31 $1,711,265 30,906
2024-09-30 $961,769 29,242
2024-06-30 $800,940 29,468
2024-03-31 $961,384 26,448
2023-12-31 $441,996 21,827
2023-09-30 $428,345 24,105
2023-06-30 $355,997 19,701
2023-03-31 $220,842 17,569
2022-12-31 $264,994 18,076